Scholarlink

Background <p>A key to understanding cancer is to determine the impact on the cellular pathways caused by the repertoire of DNA changes accrued in a cancer cell. Exploring the interactions between genomic aberrations and the expressed transcriptome can not only improve our understanding of the disease but also identify potential therapeutic approaches.</p> Results <p>Using random forest models, we successfully identified transcriptional patterns associated with the loss of wild-type activity in cancer-related genes across various tumour types. While genes like <i>TP53</i> and <i>CDKN2A</i> exhibited unique pan-cancer transcriptional patterns, others like <i>ATRX</i>, <i>BRAF</i>, and <i>NRAS</i> showed tumour-type-specific expression patterns. We also observed that genes like <i>AR</i> and <i>ERBB4</i> did not lead to strong detectable patterns in the transcriptome when disrupted. Our investigation has also led to the identification of genes highly associated with transcriptional patterns. For instance, <i>DRG2</i> emerged as the top contributor in classification of <i>ATRX</i> alterations in lower-grade gliomas and was significantly downregulated in <i>ATRX</i> mutant tumours. Additionally, transcriptional features important in classification of <i>PTEN</i> aberrations, such as <i>CDCA8</i>, <i>AURKA</i>, and <i>CDC20</i>, were found to be closely related to <i>PTEN</i> function.</p> Conclusions <p>Our findings demonstrate the utility of machine learning in interpretation of cancer genomic data and provide new avenues for development of targeted therapies tailored to individual patients with cancer. Our analysis on the transcriptome revealed genes with expression levels strongly correlated with alterations in cancer-related genes. Additionally, we identified <i>AURKA</i> inhibitors as potential therapeutic option for tumours with alterations in tumour suppressors like <i>FBXW7</i> or <i>NSD1</i>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Transcriptional patterns of cancer-related genes in primary and metastatic tumours revealed by machine learning

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月7日

查看全文
  • Faeze Keshavarz-Rahaghi,
  • Erin Pleasance,
  • Steven J. M. Jones

摘要

Background

A key to understanding cancer is to determine the impact on the cellular pathways caused by the repertoire of DNA changes accrued in a cancer cell. Exploring the interactions between genomic aberrations and the expressed transcriptome can not only improve our understanding of the disease but also identify potential therapeutic approaches.

Results

Using random forest models, we successfully identified transcriptional patterns associated with the loss of wild-type activity in cancer-related genes across various tumour types. While genes like TP53 and CDKN2A exhibited unique pan-cancer transcriptional patterns, others like ATRX, BRAF, and NRAS showed tumour-type-specific expression patterns. We also observed that genes like AR and ERBB4 did not lead to strong detectable patterns in the transcriptome when disrupted. Our investigation has also led to the identification of genes highly associated with transcriptional patterns. For instance, DRG2 emerged as the top contributor in classification of ATRX alterations in lower-grade gliomas and was significantly downregulated in ATRX mutant tumours. Additionally, transcriptional features important in classification of PTEN aberrations, such as CDCA8, AURKA, and CDC20, were found to be closely related to PTEN function.

Conclusions

Our findings demonstrate the utility of machine learning in interpretation of cancer genomic data and provide new avenues for development of targeted therapies tailored to individual patients with cancer. Our analysis on the transcriptome revealed genes with expression levels strongly correlated with alterations in cancer-related genes. Additionally, we identified AURKA inhibitors as potential therapeutic option for tumours with alterations in tumour suppressors like FBXW7 or NSD1.